Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Multiple thoughts.

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jun 12, 2024 11:28am

99 Views

Post# 36084872

RE:RE:RE:RE:Multiple thoughts.

First, no one cares what you do with your portfolio. I asked you to give me an entry and exit on Crispy weeks ago and you dodged the question.

Second, no one is arguing that ONCY could, maybe should have done things differently! You beat this point to death and we all, I think, agree. Let that go now.

Time will tell but I continue to like our prospects in the near and mid term. I'll be holding until it all comes to fruition or it's very apparent that we're going down in flames. The risk is no longer to the downside!!!

<< Previous

Bullboard Posts

Next >>

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire